These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6888239)

  • 41. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.
    Comella CL; Morrissey M; Janko K
    Neurology; 2005 Apr; 64(8):1450-1. PubMed ID: 15851743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa].
    Mizuno J; Kato S; Watada M; Morita S
    Masui; 2009 Oct; 58(10):1286-9. PubMed ID: 19860235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R; Koller WC
    Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
    [No Abstract]   [Full Text] [Related]  

  • 44. Augmentation of artistic productivity in Parkinson's disease.
    Walker RH; Warwick R; Cercy SP
    Mov Disord; 2006 Feb; 21(2):285-6. PubMed ID: 16261619
    [No Abstract]   [Full Text] [Related]  

  • 45. Medical treatment of essential tremor and Parkinson's disease.
    Uitti RJ
    Geriatrics; 1998 May; 53(5):46-8, 53-7. PubMed ID: 9597979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis and treatment of tremors.
    Koller WC
    Neurol Clin; 1984 Aug; 2(3):499-514. PubMed ID: 6398403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
    Sheffield JK; Jankovic J
    Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM; Tétreault L; Elie R
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract]   [Full Text] [Related]  

  • 49. [Basis, clinical picture and therapy of diseases of the extrapyramidal-motoric system (EPMS)].
    Völler GW; Deze J
    Z Allgemeinmed; 1975 Mar; 51(8):353-73. PubMed ID: 1094755
    [No Abstract]   [Full Text] [Related]  

  • 50. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
    Sung YH; Chung SJ; Kim SR; Lee MC
    Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying poor symptom control in Parkinson's disease.
    Scott L
    Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metoprolol in the treatment of neuroleptic-induced tremor: case report.
    Chaturvedi SK
    J Clin Psychiatry; 1987 Sep; 48(9):378. PubMed ID: 2887551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
    Schubert U; Fischer GJ; Glass J
    Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
    [No Abstract]   [Full Text] [Related]  

  • 54. High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.
    Arnold G; Gasser T; Storch A; Lipp A; Kupsch A; Hundemer HP; Schwarz J
    Arch Gerontol Geriatr; 2005; 41(3):239-53. PubMed ID: 16029905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diphenhydramine may be useful as a palliative treatment for patients dying with Parkinson's disease and tremors: a case report and discussion.
    Gonzalez F
    Am J Hosp Palliat Care; 2009 Dec-2010 Jan; 26(6):474-5. PubMed ID: 19700649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of zonisamide on resting tremor resistant to antiparkinsonian medication].
    Nakanishi I; Kohmoto J; Miwa H; Kondo T
    No To Shinkei; 2003 Aug; 55(8):685-9. PubMed ID: 13677302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Should levodopa be infused into the duodenum?
    Mouradian MM
    Neurology; 2005 Jan; 64(2):182-3. PubMed ID: 15668409
    [No Abstract]   [Full Text] [Related]  

  • 58. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pramipexole in the treatment of Parkinson's disease: new developments.
    Möller JC; Oertel WH
    Expert Rev Neurother; 2005 Sep; 5(5):581-6. PubMed ID: 16162081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of parkinsonian tremors with the beta-adrenalytic agent KL 255].
    Völler G
    Med Welt; 1969 Jan; 3():177-8. PubMed ID: 5764804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.